首页> 外国专利> HISTON DEACETYLASE (HDAC) INHIBITOR TO BE USED ALONE OR IN COMBINATION WITH CHEMOTHERAPEUTIC AGENT

HISTON DEACETYLASE (HDAC) INHIBITOR TO BE USED ALONE OR IN COMBINATION WITH CHEMOTHERAPEUTIC AGENT

机译:可以单独使用或与化学治疗剂联用的HHSTON DEACETYLASE(HDAC)抑制剂

摘要

PROBLEM TO BE SOLVED: To provide a method for treatment of cancers, especially blood cancers (multiple myeloma, leukemia, and lymphoma).;SOLUTION: Provided is a method for treatment of cancers, especially blood cancers (multiple myeloma, leukemia, and lymphoma) by administering to a patient who needs the treatment a histon deacetylase inhibitor represented by the following formula, and another chemotherapeutic agent selected from an antibody against VEGF, Avastin (R), an antibody against CD20, rituximab, bortezomib, thalidomide, dexamethasone, vincristine, doxorubicin or melphalan.;COPYRIGHT: (C)2014,JPO&INPIT
机译:解决的问题:提供一种治疗癌症,尤其是血液癌(多发性骨髓瘤,白血病和淋巴瘤)的方法。;解决方案:提供一种治疗癌症,尤其是血液癌(多发性骨髓瘤,白血病和淋巴瘤)的方法)通过向需要治疗的患者给药下式表示的组蛋白去乙酰化酶抑制剂和选自VEGF抗体的另一种化学治疗剂Avastin(R),抗CD20的抗体,利妥昔单抗,硼替佐米,沙利度胺,地塞米松,长春新碱,阿霉素或美法仑。;版权所有:(C)2014,日本特许厅&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号